A Study of Nilotinib in Growing Vestibular Schwannomas

NCT01201538 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Study PI passed away We had trouble recruiting for the drug arm

Conditions

Growing Vestibular Schwannomas

Interventions

DRUG: Nilotinib

Sponsor

University Health Network, Toronto

Collaborators

[object Object]